Skip to main content
FinSpry Logo
FinSpry
CGEN logo
CGEN
(NASDAQ)
Compugen Ltd.
$2.59-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Compugen (CGEN) Stock Price & Financial Analysis

Compugen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.54 - $2.61
52-Week High$3.24
52-Week Low$1.30
Open$2.54
Volume199.69K
Average Volume (3M)303.59K
Market Cap244.90M
Shares Outstanding94.56M
P/E Ratio (TTM)7.03
Forward P/E3.50
Price to Sales (P/S)3.37
Price to Book (P/B)2.57
EV/EBITDA7.62
Revenue (TTM)72.66M
Net Income (TTM)34.85M
Free Cash Flow (TTM)-18.79M
EPS (TTM)$0.37
Profit Margin47.97%
Operating Margin42.26%
Return on Equity (ROE)36.55%
Debt to Equity0.02
50-Day MA$2.41
200-Day MA$2.17
52-Week Change81.12%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Compugen

What is the current stock price for CGEN?

As of the latest trading session, CGEN stock trades at $2.59. The 52-week range is $1.30–$3.24, with a day range of $2.54–$2.61.

What is the P/E ratio for CGEN?

Compugen's trailing P/E ratio is 7.0, meaning investors pay $7.0 for every $1 of annual earnings. The forward P/E is 3.5, reflecting analyst expectations for future earnings. Compugen operates in the Healthcare sector.

Does CGEN pay dividends?

Compugen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CGEN?

Analyst ratings and recommendations for CGEN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CGEN?

Compugen's market capitalization is $244.9M, classifying it as a micro-cap company. Compugen operates in the Healthcare sector within the Biotechnology industry.